Spots Global Cancer Trial Database for A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifanib (ABT-869)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifanib (ABT-869)
Official Title: Ph I Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifanib (ABT-869)
Study ID: NCT01114191
Conditions
Study Description
Brief Summary: This is a phase 1, open-label study designed to determine the interaction of ketoconazole with ABT-869.
Detailed Description: This study is designed to explore the drug interaction between ketoconazole and ABT-869 to determine the potential effect of ketoconazole on the metabolism of ABT-869. ABT-869 will be taken alone or in combination with ketoconazole. The safety of a single dose administration of ABT-869 when administered alone and in combination with ketoconazole will be assessed.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Site Reference ID/Investigator# 35784, Detroit, Michigan, United States
Site Reference ID/Investigator# 36527, Lebanon, New Hampshire, United States
Contact Details
Name: Mark D McKee, MD
Affiliation: Abbott
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
